Association of β2-adrenergic receptor polymorphism with the phenotype of aspirin-intolerant acute urticaria

Yonsei Medical Journal

Volumn 48, Issue 6, 2007, Pages 1079-1081

  Kim, Hyoun Ah ^a   Ye, Young Min ^a   Kim, Seung Hyun ^a   Hur, Gyu Young ^a   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

ADRB2 polymorphism; Aspirin sensitivity; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR; IMMUNOGLOBULIN E;

ADULT; ALLERGIC RHINITIS; ALLERGIC URTICARIA; ARTICLE; ASPIRIN INTOLERANT ACUTE URTICARIA; ASPIRIN INTOLERANT CHRONIC URTICARIA; ASTHMA; ATOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; PROVOCATION TEST; STATISTICAL SIGNIFICANCE;

EID: 38049115502     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.6.1079     Document Type: Article

References (12)

1. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003;28:123-7.
2. Kim SH, Park HS. Genetic markers for differentiating aspirin-hypersensitivity. Yonsei Med J 2006;47:15-21.
3. Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980;35: 149-54.
4. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004;113:771-5.
5. Kay LJ, Peachell PT. Mast cell beta2-adrenoceptors. Chem Immunol Allergy 2005;87:145-53.
6. Kim SH, Choi JH, Holloway JW, Suh CH, Nahm DH, Ha EH, et al. Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population. J Korean Med Sci 2005;20:926-31.
7. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005;115:963-72.
8. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005;162:201-11.
9. Hughes JM; Seale JP, Temple DM. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists. Eur J Pharmacol 1983; 95:239-45.
10. Undem BJ, Peachell PT, Lichtenstein LM. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. J Pharmacol Exp Ther 1988;247:209-17.
11. Chong LK, Suvarna K, Chess-Williams R, Peachell PT. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol 2003;138:512-20.
12. Chong LK, Chowdry J, Ghahramani P, Peachell PT. Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 2000;10:153-62.